|
1
|
Henderson JM, Sherman M, Tavill A,
Abecassis M, Chejfec G and Gramlich T: AHPBA/AJCC consensus
conference on staging of hepatocellular carcinoma: Consensus
statement. HPB (Oxford). 5:243–250. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Llovet JM, Burroughs A and Bruix J:
Hepatocellular carcinoma. Lancet. 362:1907–1917. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Llovet JM, Ricci S, Mazzaferro V, Hilgard
P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A,
et al: Sorafenib in advanced hepatocellular carcinoma. N Engl J
Med. 359:378–390. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gao M, Nettles RE, Belema M, Snyder LB,
Nguyen VN, Fridell RA, Serrano-Wu MH, Langley DR, Sun JH, O'Boyle
DR II, et al: Chemical genetics strategy identifies an HCV NS5A
inhibitor with a potent clinical effect. Nature. 465:96–100. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kudo M, Chung H and Osaki Y: Prognostic
staging system for hepatocellular carcinoma (CLIP score): Its value
and limitations and a proposal for a new staging system, the Japan
integrated staging score (JIS score). J Gastroenterol. 38:207–215.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kudo M, Chung H, Haji S, Osaki Y, Oka H,
Seki T, Kasugai H, Sasaki Y and Matsunaga T: Validation of a new
prognostic staging system for hepatocellular carcinoma: The JIS
score compared with the CLIP score. Hepatology. 40:1396–1405. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nanashima A, Sumida Y, Morino S, Yamaguchi
H, Tanaka K, Shibasaki S, Ide N, Sawai T, Yasutake T, Nakagoe T and
Nagayasu T: The Japanese integrated staging score using liver
damage grade for hepatocellular carcinoma in patients after
hepatectomy. Eur J Surg Oncol. 30:765–770. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nanashima A, Sumida Y, Abo T, Shindou H,
Fukuoka H, Takeshita H, Hidaka S, Tanaka K, Sawai T, Yasutake T, et
al: Modified Japan Integrated Staging is currently the best
available staging system for hepatocellular carcinoma patients who
have undergone hepatectomy. J Gastroenterol. 41:250–256. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
A new prognostic system for hepatocellular
carcinoma: A retrospective study of 435 patients: The cancer of the
liver Italian program (CLIP) investigators. Hepatology. 28:751–755.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Prospective validation of the CLIP score:
A new prognostic system for patients with cirrhosis and
hepatocellular carcinoma. The Cancer of the Liver Italian Program
(CLIP) investigators. Hepatology. 31:840–845. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tateishi R, Yoshida H, Shiina S, Imamura
H, Hasegawa K, Teratani T, Obi S, Sato S, Koike Y, Fujishima T, et
al: Proposal of a new prognostic model for hepatocellular
carcinoma: an analysis of 403 patients. Gut. 54:419–425. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Llovet JM, Brú C and Bruix J: Prognosis of
hepatocellular carcinoma: The BCLC staging classification. Semin
Liver Dis. 19:329–338. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Llovet JM, Fuster J and Bruix J: The
Barcelona approach: Diagnosis, staging, and treatment of
hepatocellular carcinoma. Liver Transpl. 10 2 Suppl 1:S115–S120.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Poon RT, Fan ST, Ng IO, Lo CM, Liu CL and
Wong J: Different risk factors and prognosis for early and late
intrahepatic recurrence after resection of hepatocellular
carcinoma. Cancer. 89:500–507. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sumie S, Kuromatsu R, Okuda K, Ando E,
Takata A, Fukushima N, Watanabe Y, Kojiro M and Sata M:
Microvascular invasion in patients with hepatocellular carcinoma
and its predictable clinicopathological factors. Ann Surg Oncol.
15:1375–1382. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim H, Park MS, Park YN, Kim H, Kim KS,
Choi JS, Ahn SH, Han KH, Kim MJ and Kim KW: Preoperative radiologic
and postoperative pathologic risk factors for early intra-hepatic
recurrence in hepatocellular carcinoma patients who underwent
curative resection. Yonsei Med J. 50:789–795. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Park YK, Kim BW, Wang HJ and Kim MW:
Hepatic resection for hepatocellular carcinoma meeting Milan
criteria in Child-Turcotte-Pugh class a patients with cirrhosis.
Transplant Proc. 41:pp. 1691–1697. 2009; View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fan ST, Poon RT, Yeung C, Lam CM, Lo CM,
Yuen WK, Ng KK, Liu CL and Chan SC: Outcome after partial
hepatectomy for hepatocellular cancer within the Milan criteria. Br
J Surg. 98:1292–1300. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tokumitsu Y, Tamesa T, Matsukuma S,
Hashimoto N, Maeda Y, Tokuhisa Y, Sakamoto K, Ueno T, Hazama S,
Ogihara H, et al: An accurate prognostic staging system for
hepatocellular carcinoma patients after curative hepatectomy. Int J
Oncol. 46:944–952. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tokumitsu Y and Nagano H: Current HCC
Staging Systems: Their Uses and LimitationsHepatocellular
Carcinoma: Diagnosis and Treatment. Carr BI: Springer; Switzerland:
pp. 425–442. 2016, View Article : Google Scholar
|
|
22
|
Pugh RN, Murray-Lyon IM, Dawson JL,
Pietroni MC and Williams R: Transection of the oesophagus for
bleeding oesophageal varices. Br J Surg. 60:646–649. 1973.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
The general rules for the clinical and
pathological study of primary liver cancer. Kanehara; Tokyo:
2010
|
|
24
|
Clinical Practice Guidelines for
Hepatocellular Carcinoma-The Japan Society of Hepatology 2009
update. Hepatol Res. 1 40 Suppl:S2–S144. 2010.
|
|
25
|
Mazzaferro V, Regalia E, Doci R, Andreola
S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A and
Gennari L: Liver transplantation for the treatment of small
hepatocellular carcinomas in patients with cirrhosis. N Engl J Med.
334:693–699. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Minagawa M, Ikai I, Matsuyama Y, Yamaoka Y
and Makuuchi M: Staging of hepatocellular carcinoma: Assessment of
the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772
patients in Japan. Ann Surg. 245:909–922. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cho CS, Gonen M, Shia J, Kattan MW,
Klimstra DS, Jarnagin WR, D'Angelica MI, Blumgart LH and DeMatteo
RP: A novel prognostic nomogram is more accurate than conventional
staging systems for predicting survival after resection of
hepatocellular carcinoma. J Am Coll Surg. 206:281–291. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li J, Liu Y, Yan Z, Wan X, Xia Y, Wang K,
Liu J, Lau WY, Wu M and Shen F: A nomogram predicting pulmonary
metastasis of hepatocellular carcinoma following partial
hepatectomy. Br J Cancer. 110:1110–1117. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zou Q, Li J, Wu D, Yan Z, Wan X, Wang K,
Shi L, Lau WY, Wu M and Shen F: Nomograms for pre-operative and
post-operative prediction of long-term survival of patients who
underwent repeat hepatectomy for recurrent hepatocellular
carcinoma. Ann Surg Oncol. 23:2618–2626. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ang SF, Ng ES, Li H, Ong YH, Choo SP,
Ngeow J, Toh HC, Lim KH, Yap HY, Tan CK, et al: The Singapore Liver
Cancer Recurrence (SLICER) score for relapse prediction in patients
with surgically resected hepatocellular carcinoma. PLoS One.
10:e01280582015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kaido T, Mori A, Ogura Y, Hata K,
Yoshizawa A, Iida T, Yagi S and Uemoto S: Living donor liver
transplantation for recurrent hepatocellular carcinoma after liver
resection. Surgery. 151:55–60. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Iizuka N, Hamamoto Y and Oka M: Predicting
individual outcomes in hepatocellular carcinoma. Lancet.
364:1837–1839. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Iizuka N, Oka M, Yamada-Okabe H, Nishida
M, Maeda Y, Mori N, Takao T, Tamesa T, Tangoku A, Tabuchi H, et al:
Oligonucleotide microarray for prediction of early intrahepatic
recurrence of hepatocellular carcinoma after curative resection.
Lancet. 361:923–929. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kurokawa Y, Matoba R, Takemasa I, Nagano
H, Dono K, Nakamori S, Umeshita K, Sakon M, Ueno N, Oba S, et al:
Molecular-based prediction of early recurrence in hepatocellular
carcinoma. J Hepatol. 41:284–291. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Srivastava S, Wong KF, Ong CW, Huak CY,
Yeoh KG, Teh M, Luk JM and Salto-Tellez M: A morpho-molecular
prognostic model for hepatocellular carcinoma. Br J Cancer.
107:334–339. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yoshioka S, Takemasa I, Nagano H, Kittaka
N, Noda T, Wada H, Kobayashi S, Marubashi S, Takeda Y, Umeshita K,
et al: Molecular prediction of early recurrence after resection of
hepatocellular carcinoma. Eur J Cancer. 45:881–889. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Adachi E, Maeda T, Matsumata T, Shirabe K,
Kinukawa N, Sugimachi K and Tsuneyoshi M: Risk factors for
intrahepatic recurrence in human small hepatocellular carcinoma.
Gastroenterology. 108:768–775. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ikeda K, Saitoh S, Tsubota A, Arase Y,
Chayama K, Kumada H, Watanabe G and Tsurumaru M: Risk factors for
tumor recurrence and prognosis after curative resection of
hepatocellular carcinoma. Cancer. 71:19–25. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Morimoto O, Nagano H, Sakon M, Fujiwara Y,
Yamada T, Nakagawa H, Miyamoto A, Kondo M, Arai I, Yamamoto T, et
al: Diagnosis of intrahepatic metastasis and multicentric
carcinogenesis by microsatellite loss of heterozygosity in patients
with multiple and recurrent hepatocellular carcinomas. J Hepatol.
39:215–221. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sakon M, Umeshita K, Nagano H, Eguchi H,
Kishimoto S, Miyamoto A, Ohshima S, Dono K, Nakamori S, Gotoh M and
Monden M: Clinical significance of hepatic resection in
hepatocellular carcinoma: Analysis by disease-free survival curves.
Arch Surg. 135:1456–1459. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lau H, Man K, Fan ST, Yu WC, Lo CM and
Wong J: Evaluation of preoperative hepatic function in patients
with hepatocellular carcinoma undergoing hepatectomy. Br J Surg.
84:1255–1259. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wakabayashi H, Ishimura K, Izuishi K,
Karasawa Y and Maeta H: Evaluation of liver function for hepatic
resection for hepatocellular carcinoma in the liver with damaged
parenchyma. J Surg Res. 116:248–252. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kokudo N, Hasegawa K, Akahane M, Igaki H,
Izumi N, Ichida T, Uemoto S, Kaneko S, Kawasaki S, Ku Y, et al:
Evidence-based Clinical Practice Guidelines for Hepatocellular
Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC
Guidelines). Hepatol Res. 45:123–127. 2015. View Article : Google Scholar
|
|
44
|
Song P, Inagaki Y, Wang Z, Hasegawa K,
Sakamoto Y, Arita J, Tang W and Kokudo N: High levels of
gamma-glutamyl transferase and indocyanine green retention rate at
15 min as preoperative predictors of tumor recurrence in patients
with hepatocellular carcinoma. Medicine (Baltimore). 94:e8102015.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhao H, Chen C, Fu X, Yan X, Jia W, Mao L,
Jin H and Qiu Y: Prognostic value of a novel risk classification of
microvascular invasion in patients with hepatocellular carcinoma
after resection. Oncotarget. 8:5474–5486. 2017.PubMed/NCBI
|
|
46
|
Johnson PJ, Berhane S, Kagebayashi C,
Satomura S, Teng M, Reeves HL, O'Beirne J, Fox R, Skowronska A,
Palmer D, et al: Assessment of liver function in patients with
hepatocellular carcinoma: A new evidence-based approach-the ALBI
grade. J Clin Oncol. 33:550–558. 2015. View Article : Google Scholar : PubMed/NCBI
|
